DCT and melanoma: SVYDFFVWL (SL9) is a peptide derived from tyrosinase-related protein 2 (TRP2) residues 180–188 and has been identified as the primary epitope of TRP2, recognized by anti-B16 melanoma cytotoxic T lymphocytes (CTLs) [10].